Acute-on-Chronic Liver Failure Market: Key Growth Factors, Therapeutic Advances, and Forecast
Few conditions in hepatology carry the urgency of ACLF. It strikes suddenly in patients already living with chronic liver disease, pushes multiple organs toward failure within days, and yet, remarkably, still has no dedicated approved treatment anywhere in the world. That gap is exactly what's fueling momentum in the aclf market today, as drug developers across the US, EU4, UK, and Japan race...
0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр